Zhang Chuanrong, Zou Zhonghui
Department of Rheumatology and Immunology, Chongqing University Three Gorges Hospital, Chongqing, 404000, People's Republic of China.
Department of Cardiovascular Surgery, Chongqing University Three Gorges Hospital, Chongqing, 404100, People's Republic of China.
Int J Gen Med. 2025 Jun 28;18:3515-3524. doi: 10.2147/IJGM.S515976. eCollection 2025.
To construct Risk Predictive Nomogram in patients of connective tissue disease (CTD) with severe pneumonia.
Eighty CID patients with severe pneumonia in rheumatology and respiratory department of chongqing University Three Gorges hospital from January 2020 to December 2022 were retrospectively reviewed and analyzed. Independent risk factors for severe pneumonia in CTD were screened by univariate and binomial logistic regression analysis. The nomogram was constructed by R software. Area under the curve (AUC) of receiver operating characteristic (ROC) was used to evaluate the nomogram's discrimination, and the calibration curve and Hosmer-Lemeshow test were used to reflect the nomogram's calibration.
The study cohort was including 48 patients in the general pneumonia group and 32 patients in the severe pneumonia group. The model variables included Ln CD4/CD8, Ln CRP, Ln PCT and Ln IFN-γ. Hosmer-lemeshow test P value less than 0.05 (χ2 = 7.753, = 0.458), the area under ROC curve of nomogram was 0.9084 (95% CI: 0.8461-0.9707), and the optimal cutoff value of nomogram was 0.490, the sensitivity was 0.872, the specificity was 0.848. In a retrospective study design, 50 patients with CTD complicated with pneumonia admitted to the same hospital from January to June 2023 were selected to verify the model. The nomogram verification results showed Hosmer-Lemeshow test (χ2 = 7.1171, = 0.5241), AUC value was 0.8958 (95% CI: 0.808-0.9837), and optimal cutoff value was 0.664, the sensitivity was 0.988, the specificity was 0.812.
The prediction nomogram in this study is helpful for clinical staffs to screen high-risk patients with severe pneumonia in CTD, and has high clinical application value.
构建结缔组织病(CTD)合并重症肺炎患者的风险预测列线图。
回顾性分析2020年1月至2022年12月重庆三峡中心医院风湿免疫科和呼吸内科收治的80例CTD合并重症肺炎患者的临床资料。通过单因素和二元逻辑回归分析筛选CTD合并重症肺炎的独立危险因素。使用R软件构建列线图。采用受试者操作特征曲线(ROC)下面积(AUC)评估列线图的辨别力,校准曲线和Hosmer-Lemeshow检验反映列线图的校准情况。
研究队列包括普通肺炎组48例患者和重症肺炎组32例患者。模型变量包括Ln CD4/CD8、Ln CRP、Ln PCT和Ln IFN-γ。Hosmer-Lemeshow检验P值小于0.05(χ2 = 7.753,P = 0.458),列线图的ROC曲线下面积为0.9084(95%CI:0.8461 - 0.9707),列线图的最佳截断值为0.490,灵敏度为0.872,特异度为0.848。在一项回顾性研究设计中,选取2023年1月至6月在同一医院住院的50例CTD合并肺炎患者对模型进行验证。列线图验证结果显示Hosmer-Lemeshow检验(χ2 = 7.1171,P = 0.5241),AUC值为0.8958(95%CI:0.808 - 0.9837),最佳截断值为0.664,灵敏度为0.988,特异度为0.812。
本研究构建的预测列线图有助于临床医护人员筛查CTD合并重症肺炎的高危患者,具有较高的临床应用价值。